The stock of Bovie Medical Corporation (NYSEMKT:BVX) is a huge mover today! About 539,024 shares traded hands or 115.02% up from the average. Bovie Medical Corporation (NYSEMKT:BVX) has risen 118.14% since February 26, 2016 and is uptrending. It has outperformed by 107.71% the S&P500.
The move comes after 7 months positive chart setup for the $142.74 million company. It was reported on Sep, 30 by Barchart.com. We have $15.36 PT which if reached, will make NYSEMKT:BVX worth $274.06M more.
Analysts await Bovie Medical Corporation (NYSEMKT:BVX) to report earnings on November, 2. They expect $-0.03 EPS, up 57.14% or $0.04 from last year’s $-0.07 per share. After $-0.02 actual EPS reported by Bovie Medical Corporation for the previous quarter, Wall Street now forecasts 50.00% negative EPS growth.
According to Zacks Investment Research, “Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devices and advanced coating technologies.”
Insitutional Activity: The institutional sentiment decreased to 0.54 in 2016 Q2. Its down 0.60, from 1.14 in 2016Q1. The ratio dropped, as 7 funds sold all Bovie Medical Corporation shares owned while 6 reduced positions. 2 funds bought stakes while 5 increased positions. They now own 4.70 million shares or 6.35% less from 5.02 million shares in 2016Q1.
Blackrock Advsrs Ltd accumulated 0% or 7,643 shares. Deutsche Bank Ag accumulated 0% or 250 shares. Savings Bank Of America Corporation De, a North Carolina-based fund reported 102 shares. Kennedy Cap Management last reported 0% of its portfolio in the stock. Creative Planning, a Kansas-based fund reported 1,475 shares. Tower Rech Cap Limited Liability (Trc) last reported 0% of its portfolio in the stock. The Massachusetts-based Geode Capital Management Ltd Liability Corporation has invested 0% in Bovie Medical Corporation (NYSEMKT:BVX). Manufacturers Life Insurance The last reported 2,283 shares in the company. Wasatch Advisors Incorporated, a Utah-based fund reported 340,000 shares. Morgan Stanley holds 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX) for 6,700 shares. Dimensional Fund Advsr Lp has 0% invested in the company for 278,943 shares. Perkins accumulated 355,740 shares or 0.67% of the stock. Blackrock Inv Limited Liability Corporation has 0% invested in the company for 4,801 shares. Vanguard Gp holds 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX) for 540,757 shares. The Kansas-based Vsr has invested 0.01% in Bovie Medical Corporation (NYSEMKT:BVX).
Insider Transactions: Since August 17, 2016, the stock had 1 insider purchase, and 0 sales for $299,475 net activity. McCarthy John J. III bought $299,475 worth of stock or 90,750 shares.
More important recent Bovie Medical Corporation (NYSEMKT:BVX) news were published by: Businesswire.com which released: “Bovie Medical Corporation Reports Second Quarter and First Half 2016 Results” on August 01, 2016, also Businesswire.com published article titled: “Bovie Medical Corporation Hires J-Plasma Product Development Manager”, Seekingalpha.com published: “Bovie Medical’s Turnaround Is Here” on March 01, 2016. More interesting news about Bovie Medical Corporation (NYSEMKT:BVX) was released by: Seekingalpha.com and their article: “Bovie Medical’s (BVX) CEO Robert Gershon on Q1 2016 Results – Earnings Call …” with publication date: May 11, 2016.
BVX Company Profile
Bovie Medical Corporation (Bovie), incorporated on December 3, 1982, is an energy medical device company. The Firm is also engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. The Firm operates through three divisions: Core, OEM and J-Plasma. The Firm is engaged in developing, manufacturing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor’s offices, surgery centers and hospitals around the world. It also develops J-Plasma, a helium plasma surgical product. The J-Plasma system consists of an electrosurgical generator unit (ESU), a handpiece and a supply of helium gas. The Company’s medical devices are marketed through its own brands, including Bovie, Aaron, DERM, IDS and ICON, and on a private label basis to distributors around the world. The Firm offers its products in three categories: electrosurgery, cauteries and other products.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.